Jaimie Marie Heldstab

Dynamic Oncology Nurse Practitioner with expertise in breast cancer care, clinical trials, and patient education. Proven ability to lead presentations and collaborate effectively, driving optimal patient outcomes.

• Gilead Speakers Bureau, 07/21 - Present
• Merck Speakers Bureau, 01/21
• Novartis Advisory Board Member, 01/17 - Present
• Presented SOLAR-1 (Alpelisib) at the 2021 AONN Conference, Showcasing leadership in oncology research and clinical data dissemination.

• CtDNA and Residual Cancer Burden are Prognostic in Triple-Negative Breast Cancer Patients with Residual Disease, Sharma, P., Stecklein, S., Heldstab, J., et al., Accepted to NPJ Breast Cancer, 02/23
• Clinical and biomarker results from Phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer, Sharma, P., Abramson VG, O’Dea A, et al., Clin Cancer Res, 2021, 10.1158/1078-0432. CCR-20-4879
• Efficacy of neoadjuvant carboplatin plus docetaxel in triple-negative breast cancer, Sharma, P., Lopez-Tarruella, S., Heldstab, J., et al., Clin Cancer Res, 23, 3, 649-657, 2017

• Advanced Oncology Certified Nurse Practitioner (AOCNP), 06/16
• City of Hope Genetic Counselor Certification, 06/20
• Lymphedema Therapy: Upper Extremity, 06/15
• American Nurses Credentialing Center (ANCC), 06/13
• Basic Life Support Instructor, 06/10
• Chemotherapy/Biotherapy Certification, 06/09

• Oncology Expertise: Extensive background in oncology, specializing in breast cancer, chemotherapy, immunotherapy, and clinical trials.
• Strong Communication & Education Skills: Experience in educating both patients and healthcare professionals about treatment options and clinical outcomes.
• Sales and Business Development: Ability to build lasting relationships with healthcare providers, support physicians with product knowledge, and contribute to the growth of oncology therapeutics.
• Industry Knowledge & Clinical Trials: In-depth knowledge of clinical trial design, biomarker testing, and oncology therapeutic pathways.
• Collaboration & Team Leadership: Proven ability to lead multidisciplinary teams and collaborate with pharmaceutical stakeholders and research groups.
• Strategic Market Insight: Insight into the evolving oncology landscape, with familiarity in emerging therapies and the competitive market environment.
• Regulatory & Compliance Knowledge: Familiar with FDA regulations, clinical trial procedures, and ethical medical practices.